GL1X · GenesisL1 explorer

MolNFT v1 · #185973 · protein

The receptor binding domain of SARS-cov-2 omicron variant spike glycoprotein in complex with beta-55 and EY6A fabs

7QNW: “The receptor binding domain of SARS-cov-2 omicron variant spike glycoprotein in complex with beta-55 and EY6A…”. X-ray diffraction, 2 ligands (NAG, CL). MolNFT v1 #185973 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
7QNW
Type
protein
Length
1,057 residues
Chains
5
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
A0A7U3CI26
Ligands
NAG, CL

Structure

x-ray diffraction · 5 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
H—protein215——
L—protein212——
E—protein188—A0A7U3CI26
A—protein228——
B—protein214——

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains E
  • CL · Chloride ion · ion · chains A, B
  • GOL · Glycerol · additive · 9 copies · chains H, L, E, A, B
  • ACT · Acetate ion · additive · 2 copies · chains E, A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 7QNW · The receptor binding domain of SARS-CoV-2 Omicron variant spike glycoprotein in complex… · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.